China Universal Asset Management Company’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

China Universal Asset Management Company’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-487	Closed	-$2.84K	–	455
2022 Q4	$2.84K	Buy	+487	New	+$2.56K	﹤0.01%	348

China Universal Asset Management Company's CNCE Position: Q1 2023 in Review

China Universal Asset Management Company sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 487 shares — an estimated $2.84K sold.

China Universal Asset Management Company first reported a position in CNCE in Q4 2022 and held it in 1 quarter. The position peaked at $2.84K in Q4 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

China Universal Asset Management Company reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
China Universal Asset Management Company sold 487 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $2.84K.
China Universal Asset Management Company first reported a position in Concert Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
China Universal Asset Management Company's Concert Pharmaceuticals, Inc. position peaked at $2.84K in Q4 2022.
0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on China Universal Asset Management Company's 13F filing for Q1 2023, filed 28 Apr 2023.